Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Evaluate Toxicogenomics Data for FDA

NEW YORK, Aug. 19 (GenomeWeb News) - Gene Logic has entered into an agreement with the US Food and Drug Administration's Center for Drug Evaluation and Research to use its gene expression data from control and treated rats to evaluate toxicogenomics data, the company said today.

 

The agreement is designed to assist the FDA in assessing quality of genomics data that is part of new drug submissions. The company said the results of the research will be publicly available.

 

"We are excited about working closely with Gene Logic scientists in the pursuit of our shared vision of evaluating standards which may become critical for future regulatory submissions," Karol Thompson, who will be the primary CDER investigator on this project, said in a statement. "In building on this agreement, we look forward to additional joint research efforts with Gene Logic aimed at increasing the safety and efficacy profile of drugs."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.